Validity of an instrument to measure the impact of valve heart disease on the patient's daily life

Padilha, Kátia Melissa; Gallani, Maria Cecília Bueno Jayme; Colombo, Roberto

doi:10.1111/j.1365-2702.2007.01765.x

Cited by 13 publications

(48 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The fact that the domain, Adaptation to the disease, did not identify differences between groups was attributed to its composition, with only two non correlated items, as evidenced in other studies (7)(8) .…”

Section: Referencesmentioning

confidence: 58%

“…Lower scores mean that patient does not recognize the disease and treatment consequences in his life and, if they occur, they are not evaluated as bad. Although this instrument has been developed to evaluate beliefs of patients with valvular heart disease (7) , it was observed that the IDCV can also be used to evaluate the impact imposed by cardiac disease chronicity (7) . A previous study demonstrated its reliability and validity for assessment of the disease impact among patients with CAD (8) .…”

Section: Instrument To Measure the Impact Of Coronary Disease On Patimentioning

confidence: 99%

“…an instrument constructed in the Brazilian culture to assess the impact of valvulopathy in the daily life of valvular heart disease patients (7). The concept is that the impact is the product of disease repercussions; the assessment of each consequence led to the development of two parts (A and B), each with 14 items.…”

Section: Instrument To Measure the Impact Of Coronary Disease On Patimentioning

confidence: 99%

“…Assuming that the impact of the disease results from the balance between a subject's perception of consequences of the disease on the different dimensions of his life, and evaluation (good or bad) of those consequences, it is likely that those who experience a very negative impact of the disease have a worse evaluation of their quality of life (7) .…”

Section: Introductionmentioning

confidence: 99%

“…The instrument was called the Instrument to Measure the Impact of Coronary Disease on Patient's Everyday Life (IDCV) and presented satisfactory measurement properties when applied to patients with valvular heart disease (7) . Although the instrument was developed to measure impact among patients with valvular heart disease, the refinement of its items resulted in selection of pertinent aspects to measuring impact on other cardiac conditions with similar symptoms (8) .…”

Section: Introductionmentioning

confidence: 99%

See 4 more Smart Citations

Medida do impacto da doença: validade de constructo de instrumento entre coronariopatas

Pedrosa

Rodrigues

Padilha

et al. 2013

Rev. esc. enferm. USP

Self Cite

View full text Add to dashboard Cite

RESUMOMann-Whitney test was used to verify the ability of IDCV in discriminating impact of signs and symptoms, LVEF and ventricular systolic dysfunction. Also, the Kruskal-Wallis test was used to verify the discrimination power of the IDCV in relation to HRQoL. It was observed that the IDCV discriminated the impact between variables scored in HRQOL quartiles (≤Q1, Q1-Q3, ≥Q3). The study findings contribute for improvement of IDCV in measurement of disease impact in coronary artery disease patients. DESCRIPTORS Coronary disease Quality of life Sickness impact profile Validation studies RESUMENEste estudio tuvo como objetivo estimar la validez de constructo por medio de pruebas en grupos conocidos del Instrumento para Medición del Impacto de la Enfermedad en la vida diaria del paciente con valvulopatía, relacionado a la búsqueda de signos y síntomas, función ventricular sistólica, fracción de eyección ventricular izquierda (FEVI) y la calidad de vida relacionada con la salud (CVRS). Fue ejecutado en 153 pacientes con enfermedad coronaria que realizaban control regular en los consultorios externos. La recolección de los datos fue a través de la aplicación del instrumento específico y de las versiones brasileñas del The Medical Study 36-item Short Form Health Survey -SF-36 y MacNew Heart Disease Health-related Quality of Life Questionnaire. Fue utilizado la prueba de Mann-Whitney para verificar la capacidad del Instrumento para Medición del Impacto de la Enfermedad en la vida diaria del paciente con valvulopatía y discriminar el impacto en relación con los signos y síntomas, la fracción de eyección ventricular izquierda (FEVI) y la disfunción sistólica ventricular izquierda; así como la prueba de Kruskal-Wallis para comprobar el poder de discriminación en relación con la CVRS. Fue constatado que el IDCV fue capaz de discriminar el impacto entre los sujetos que puntuaron en los cuartiles (≤Q1, Q1-Q3, ≥Q3) de la CVRS. Los resultados del estudio contribuyen para el perfeccionamiento del IDCV en la medición del impacto de la enfermedad en pacientes con enfermedad coronaria.

show abstract

Section: Referencesmentioning

confidence: 58%

Section: Instrument To Measure the Impact Of Coronary Disease On Patimentioning

confidence: 99%

Section: Instrument To Measure the Impact Of Coronary Disease On Patimentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 3 more Smart Citations

Medida do impacto da doença: validade de constructo de instrumento entre coronariopatas

Pedrosa

Rodrigues

Padilha

et al. 2013

Rev. esc. enferm. USP

Self Cite

View full text Add to dashboard Cite

show abstract

Placing patient-reported outcomes at the centre of cardiovascular clinical practice: implications for quality of care and management

Moons,

Norekvål,

Arbelo

et al. 2023

European Heart Journal

View full text Add to dashboard Cite

Patient-reported outcomes (PROs) provide important insights into patients’ own perspectives about their health and medical condition, and there is evidence that their use can lead to improvements in the quality of care and to better-informed clinical decisions. Their application in cardiovascular populations has grown over the past decades. This statement describes what PROs are, and it provides an inventory of disease-specific and domain-specific PROs that have been developed for cardiovascular populations. International standards and quality indices have been published, which can guide the selection of PROs for clinical practice and in clinical trials and research; patients as well as experts in psychometrics should be involved in choosing which are most appropriate. Collaborations are needed to define criteria for using PROs to guide regulatory decisions, and the utility of PROs for comparing and monitoring the quality of care and for allocating resources should be evaluated. New sources for recording PROs include wearable digital health devices, medical registries, and electronic health record. Advice is given for the optimal use of PROs in shared clinical decision-making in cardiovascular medicine, and concerning future directions for their wider application.

show abstract

Validation of an instrument to measure the impact of coronary disease on patient’s daily life

Santos

Rodrigues²,

Padilha³

et al. 2011

Journal of Clinical Nursing

View full text Add to dashboard Cite

show abstract

Validity of an instrument to measure the impact of valve heart disease on the patient's daily life

Abstract: The Heart Valve Disease Impact on daily life could be a useful instrument to measure the impact of heart valve disease and to evaluate the response to health interventions.

Cited by 13 publications

References 21 publications

Medida do impacto da doença: validade de constructo de instrumento entre coronariopatas

Medida do impacto da doença: validade de constructo de instrumento entre coronariopatas

Placing patient-reported outcomes at the centre of cardiovascular clinical practice: implications for quality of care and management

Validation of an instrument to measure the impact of coronary disease on patient’s daily life

Contact Info

Product

Resources

About